Found: 69
Select item for more details and to access through your institution.
Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01119-4
- By:
- Publication type:
- Article
P‐tau235: a novel biomarker for staging preclinical Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 12, p. 1, doi. 10.15252/emmm.202115098
- By:
- Publication type:
- Article
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 12, p. 1, doi. 10.15252/emmm.202012921
- By:
- Publication type:
- Article
N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cerebrospinal fluid p‐tau181, 217, and 231 in definite Creutzfeldt–Jakob disease with and without concomitant pathologies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5324, doi. 10.1002/alz.13907
- By:
- Publication type:
- Article
Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots—A new collection method for remote settings.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 4, p. 2340, doi. 10.1002/alz.13697
- By:
- Publication type:
- Article
Plasma pTau‐217 and N‐terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid‐β positive individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 2, p. 1166, doi. 10.1002/alz.13528
- By:
- Publication type:
- Article
Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 2, p. 1284, doi. 10.1002/alz.13518
- By:
- Publication type:
- Article
Exploring biomarker profiles of the cognitively unimpaired individuals in early tau PET Braak stage.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077921
- By:
- Publication type:
- Article
Plasma biomarkers of tau for the differentiation between slow and fast tau‐PET accumulators.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080098
- By:
- Publication type:
- Article
Plasma ALZpath p‐tau217 for the identification of amyloid and tau positivity.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079892
- By:
- Publication type:
- Article
Identifying Optimal Blood Tau Epitopes for the Detection of Alzheimer's Disease Neuropathology: An Immunoprecipitation Mass Spectrometry and Autopsy Study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079730
- By:
- Publication type:
- Article
Plasma biomarkers rates of change across the preclinical stage of Alzheimer's disease: a longitudinal study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079638
- By:
- Publication type:
- Article
Plasma p‐tau and brain‐derived total tau biomarkers predict longitudinal changes in Aβ, tau, and cognition across the AD continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078070
- By:
- Publication type:
- Article
Plasma p‐tau212 is an early biomarker to identify Alzheimer's Disease pathology in Down Syndrome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076229
- By:
- Publication type:
- Article
Plasma biomarkers of tau for the differentiation between slow and fast tau‐PET accumulators.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081969
- By:
- Publication type:
- Article
Exploring biomarker profiles of the cognitively unimpaired individuals in early tau PET Braak stage.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081775
- By:
- Publication type:
- Article
Levels of Alzheimer's disease blood biomarkers are altered after food intake—A pilot intervention study in healthy adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 12, p. 5531, doi. 10.1002/alz.13163
- By:
- Publication type:
- Article
Plasma and CSF concentrations of N‐terminal tau fragments associate with in vivo neurofibrillary tangle burden.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 12, p. 5343, doi. 10.1002/alz.13119
- By:
- Publication type:
- Article
Plasma and CSF biomarkers in a memory clinic: Head‐to‐head comparison of phosphorylated tau immunoassays.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 5, p. 1913, doi. 10.1002/alz.12841
- By:
- Publication type:
- Article
Simultaneous Mass Spectrometric quantification of multiple p‐tau species in plasma – findings along the Alzheimer´s disease continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069305
- By:
- Publication type:
- Article
Plasma biomarkers associations with cognitive change in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.068847
- By:
- Publication type:
- Article
Voxel‐wise Staging of Tau Pathology using [<sup>18</sup>F]RO‐948 PET in the Early AD Continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.067806
- By:
- Publication type:
- Article
[<sup>18</sup>F]RO‐948 Tau PET Retention and Correlation with Fluid Tau Biomarkers in the Early AD Continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.065900
- By:
- Publication type:
- Article
Neuropathological validation of plasma GFAP.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.066008
- By:
- Publication type:
- Article
A head‐to‐head comparison of plasma phosphorylated tau assays in the real‐world memory clinic.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.065391
- By:
- Publication type:
- Article
Tau phosphorylation is more closely associated with amyloid‐β plaques than with tau neurofibrillary tangles.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.064277
- By:
- Publication type:
- Article
Biomarker modelling of Alzheimer's disease using in vivo Braak staging.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.062540
- By:
- Publication type:
- Article
Tau protein profiling across brain of different tauopathies using high‐resolution mass spectrometry: quantification of isoforms and phosphorylations.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 1, doi. 10.1002/alz.069316
- By:
- Publication type:
- Article
Tau phosphorylation is more closely associated with amyloid‐β plaques than with tau neurofibrillary tangles.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, p. 1, doi. 10.1002/alz.064231
- By:
- Publication type:
- Article
CSF biomarkers and plasma p‐tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 12, p. 2614, doi. 10.1002/alz.12570
- By:
- Publication type:
- Article
Plasma p‐tau231 in the Alzheimer's disease continuum: A multi‐cohort evaluation of diagnostic performance, detection of Aβ pathology and preclinical application.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056186
- By:
- Publication type:
- Article
Mass spectrometric measurement of six site‐specific tau phosphorylations in CSF and blood of Alzheimer's disease patients.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055985
- By:
- Publication type:
- Article
Distinctive effect of biological sex in AD‐related CSF and plasma biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052959
- By:
- Publication type:
- Article
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 7, p. 1145, doi. 10.1002/alz.12283
- By:
- Publication type:
- Article
Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 5, p. 755, doi. 10.1002/alz.12236
- By:
- Publication type:
- Article
Plasma p‐tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post‐mortem and improves the clinical characterisation of cognitive decline: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047539
- By:
- Publication type:
- Article
An extensive plasmid library for preparing tau variants and studying their functional biochemistry: Molecular and cell biology/tau.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045387
- By:
- Publication type:
- Article
CSF phosphorylated tau‐217 is increased in Alzheimer's and Creutzfeldt‐Jakob diseases and correlates with amyloid pathology: Biomarkers (non‐neuroimaging) / Novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045296
- By:
- Publication type:
- Article
The effect of physical activity on CSF biomarkers of Alzheimer's disease differs between men and women: Biomarkers (non‐neuroimaging): Alzheimer's disease incidence, risk factors and biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044722
- By:
- Publication type:
- Article
Amyloid‐β, tau, synaptic dysfunction, neurodegeneration, glial and vascular biomarkers in the preclinical stage of the Alzheimer's continuum: Biomarkers (non‐neuroimaging) / novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044444
- By:
- Publication type:
- Article
Truncating tau reveals different pathophysiological actions of oligomers in single neurons.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02791-x
- By:
- Publication type:
- Article
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24319-x
- By:
- Publication type:
- Article
Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-020-00754-8
- By:
- Publication type:
- Article
AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin.
- Published in:
- Diabetologia, 2017, v. 60, n. 4, p. 729, doi. 10.1007/s00125-017-4211-9
- By:
- Publication type:
- Article
Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillations.
- Published in:
- Acta Neuropathologica Communications, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40478-023-01562-5
- By:
- Publication type:
- Article
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 3, p. 255, doi. 10.1001/jamaneurol.2023.5319
- By:
- Publication type:
- Article
Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 1, p. 69, doi. 10.1001/jamaneurol.2023.4596
- By:
- Publication type:
- Article